LivaNova PLC

54.79-3.35-5.76%Vol 492.93K1Y Perf -20.73%
Feb 6th, 2023 16:00 DELAYED
BID40.99 ASK88.16
Open57.71 Previous Close58.14
Pre-Market- After-Market54.79
 - -  - -%
Target Price
80.57 
Analyst Rating
Strong Buy 1.50
Potential %
47.05 
Finscreener Ranking
★+     43.31
Insiders Trans % 3/6/12 mo.
-/-100/-86 
Value Ranking
★+     43.95
Insiders Value % 3/6/12 mo.
-/-100/-88 
Growth Ranking
★+     41.66
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-89 
Income Ranking
 —    -
Price Range Ratio 52W %
28.09 
Earnings Rating
Buy
Market Cap2.93B 
Earnings Date
22nd Feb 2023
Alpha-0.00 Standard Deviation0.11
Beta0.92 

Today's Price Range

54.3758.01

52W Range

41.8288.00

5 Year PE Ratio Range

-149.70-13.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-2.51%
1 Month
-2.77%
3 Months
9.95%
6 Months
-11.46%
1 Year
-20.73%
3 Years
-25.16%
5 Years
-34.23%
10 Years
-

TickerPriceChg.Chg.%
LIVN54.79-3.3500-5.76
AAPL151.73-2.7700-1.79
GOOG103.47-1.7500-1.66
MSFT256.77-1.5800-0.61
XOM111.73-0.1900-0.17
WFC47.680.10000.21
JNJ163.36-1.2500-0.76
FB196.640.99000.51
GE82.350.39000.48
JPM141.920.83000.59
 
ProfitabilityValueIndustryS&P 500US Markets
71.30
-4.20
1.70
-13.40
-11.77
RevenueValueIndustryS&P 500US Markets
746.93M
13.96
-2.62
-2.43
Earnings HistoryEstimateReportedSurprise %
Q03 20220.570.581.75
Q02 20220.510.533.92
Q01 20220.520.48-7.69
Q04 20210.500.5714.00
Q03 20210.450.6851.11
Q02 20210.320.5262.50
Q01 20210.150.35133.33
Q04 20200.660.717.58
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.720.00-
12/2022 FY1.73-9.42Negative
3/2023 QR0.44-31.25Negative
12/2023 FY2.46-2.77Negative
Next Report Date22nd Feb 2023
Estimated EPS Next Report0.72
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume492.93K
Shares Outstanding53.52K
Shares Float46.90M
Trades Count9.22K
Dollar Volume27.31M
Avg. Volume463.29K
Avg. Weekly Volume567.84K
Avg. Monthly Volume452.48K
Avg. Quarterly Volume369.55K

LivaNova PLC (NASDAQ: LIVN) stock closed at 54.79 per share at the end of the most recent trading day (a -5.76% change compared to the prior day closing price) with a volume of 492.93K shares and market capitalization of 2.93B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 4000 people. LivaNova PLC CEO is Damien McDonald.

The one-year performance of LivaNova PLC stock is -20.73%, while year-to-date (YTD) performance is -1.35%. LIVN stock has a five-year performance of -34.23%. Its 52-week range is between 41.82 and 88, which gives LIVN stock a 52-week price range ratio of 28.09%

LivaNova PLC currently has a PE ratio of -33.10, a price-to-book (PB) ratio of 2.63, a price-to-sale (PS) ratio of 4.01, a price to cashflow ratio of 35.50, a PEG ratio of 2.32, a ROA of -4.56%, a ROC of -4.13% and a ROE of -8.24%. The company’s profit margin is -11.77%, its EBITDA margin is 1.70%, and its revenue ttm is $746.93 Million , which makes it $13.96 revenue per share.

Of the last four earnings reports from LivaNova PLC, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.72 for the next earnings report. LivaNova PLC’s next earnings report date is 22nd Feb 2023.

The consensus rating of Wall Street analysts for LivaNova PLC is Strong Buy (1.5), with a target price of $80.57, which is +47.05% compared to the current price. The earnings rating for LivaNova PLC stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

LivaNova PLC has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

LivaNova PLC has a Buy technical analysis rating based on Technical Indicators (ADX : 21.32, ATR14 : 1.68, CCI20 : 186.94, Chaikin Money Flow : 0.09, MACD : 0.50, Money Flow Index : 59.05, ROC : 2.87, RSI : 62.52, STOCH (14,3) : 76.34, STOCH RSI : 1.00, UO : 50.82, Williams %R : -23.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of LivaNova PLC in the last 12-months were: Alex Shvartsburg (Option Excercise at a value of $-32 682), Alfred J Novak (Option Excercise at a value of $0), Andrea L. Saia (Option Excercise at a value of $0), Arthur L Rosenthal (Option Excercise at a value of $0), Damien McDonald (Option Excercise at a value of $0), Damien McDonald (Sold 5 004 shares of value $348 019 ), Daniel Jeffrey Moore (Option Excercise at a value of $0), Daniel Jeffrey Moore (Sold 3 000 shares of value $243 416 ), Francesco Bianchi (Option Excercise at a value of $0), Keyna Pidcock Skeffington (Option Excercise at a value of $0), Marco Dolci (Option Excercise at a value of $0), Sharon O'Kane (Option Excercise at a value of $0), Stacy Enxing Seng (Option Excercise at a value of $0), Todd C. Schermerhorn (Option Excercise at a value of $0), Trui Hebbelinck (Option Excercise at a value of $0), William A. Kozy (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (66.67 %)
4 (66.67 %)
5 (83.33 %)
Moderate Buy
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Hold
1 (16.67 %)
1 (16.67 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.17

LivaNova PLC

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.

CEO: Damien McDonald

Telephone: +44 2033250660

Address: 20 Eastbourne Terrace, London W2 6LG, , GB

Number of employees: 4 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

40%60%

Bearish Bullish

51%49%

TipRanks News for LIVN

Wed, 02 Nov 2022 17:00 GMT Analysts Top Healthcare Picks: LivaNova (LIVN), Surface Oncology (SURF)

- TipRanks. All rights reserved.

Wed, 03 Aug 2022 18:15 GMT LivaNova (LIVN) Gets a Buy Rating from Needham

- TipRanks. All rights reserved.

News

Stocktwits